Fundz

Linnaeus Therapeutics reported raising $1.63 Million in an initial SEC Form D filing, from an offering of $3.92 Million

PRIVATEAug 12, 2024$1.6M of $3.9M raised

Amount Raised

$1.63 Million

$1.63 Million sold, per SEC Form D (first sale Aug 12, 2024)

Round Type

Venture

HaddonfieldBiotechnologyresearch

Quick answer

Linnaeus Therapeutics raised $1.63 Million in a funding round, dated August 12, 2024. Linnaeus Therapeutics is based in Haddonfield, New Jersey, United States.

How much did Linnaeus Therapeutics raise?
Linnaeus Therapeutics raised $1.63 Million in a funding round on August 12, 2024.
What does Linnaeus Therapeutics do?
Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled..
Where is Linnaeus Therapeutics based and how big is it?
Linnaeus Therapeutics is based in Haddonfield, New Jersey, United States. Fundz records about 5 employees.
Who are the decision-makers at Linnaeus Therapeutics?
Fundz holds 2 contacts at Linnaeus Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Linnaeus Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Somite raised $4.8M (Pre-Seed) on September 9, 2024.
  • Micropep Technologies raised $29M (Series B) on July 25, 2024.
  • FOXO Technologies raised $235K on July 17, 2024.
  • FOXO Technologies raised $290K on July 17, 2024.
  • PACT raised $12M (Seed) on September 26, 2024.
  • SURGAR raised $12M (Funding Round) on September 26, 2024.

Who to call at Linnaeus Therapeutics, and when

A new round usually means Linnaeus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Linnaeus Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Linnaeus Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Linnaeus Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Linnaeus Therapeutics

Location

30 WASHINGTON AVENUE, SUITE F

Haddonfield, New Jersey, United States

About

Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Linnaeus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsPatrick M., Executive Officer, Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Linnaeus Therapeutics's next move

See what Strategic adds

Linnaeus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.